- Home
- Collections
- Congress on Demand 2021: Internal Medicine
Congress on Demand 2021: Internal Medicine
We are pleased to present a selection of lectures from BSAVA virtual Congress 2021 that cover internal medicine. This collection can be purchased as a standalone item, with a discount for BSAVA members. Visit our Congress on Demand information page for information about how to access the rest of our 2021 congress lectures.
Collection Contents
4 results
-
-
The asymptomatic patient
BSAVA Congress Proceedings 2021Authors: Adrian Boswood and Jose Novo MatosAsymptomatic patients: I am hearing a heart murmur for the first time in an adult dog. What should I do? Incidentally discovered heart murmurs in adult dogs are common. Degenerative (myxomatous) mitral valve disease (DMVD) is by far the most common cause of acquired murmurs in dogs. Other possible causes would include dilated cardiomyopathy, bacterial endocarditis, previously undiscovered congenital heart disease and non-cardiac causes such as haemic murmurs and flow murmurs. In dogs with an appropriate signalment, a murmur with timing and location consistent with mitral regurgitation makes DMVD very likely. Factors that might make this less likely (or rule it out altogether) would include; the finding of a murmur that is audible continuously or in diastole, finding a murmur in a large breed dog or the presence of clinical signs indicative of significant systemic disease e.g. pallor or pyrexia. The single best diagnostic test to determine whether or not a murmur is caused by cardiac disease and to characterise the specific cause of a murmur is echocardiography. In some circumstances, echocardiography may not be possible due to cost or lack of access to appropriate equipment or expertise. In a patient suspected of having DMVD it is important to stage their disease as accurately as possible to ensure appropriate treatment can be instituted if appropriate.
Asymptomatic patients: I am hearing a heart murmur for the first time in an adult cat. What should I do? Cardiomyopathies are the most common heart diseases in cats with hypertrophic cardiomyopathy (HCM) being the most prevalent form. HCM affects 15% of apparently healthy cats. Cardiac auscultation in cats is challenging as it lacks both sensitivity and specificity. Cardiomyopathies may not cause a heart murmur, thus some cats with clinically significant heart disease have a normal cardiac auscultation. Conversely, a murmur may be present in some cats with structurally normal hearts. Thus, absence/presence of murmurs may not always help in determining which cats have heart disease. However, the majority of cats with a murmur do have structural heart disease, especially older cats with loud (≥3/6) murmurs. In HCM, murmurs are commonly caused by dynamic LV outflow tract obstruction. Normal cats can have murmurs due to dynamic RV outflow tract obstruction (clinically benign). NT-proBNP is increased in cats with moderate-severe asymptomatic cardiomyopathy, thus it may be used as a first-line test to assess the likelihood of heart disease in a cat with a murmur. But echocardiography is required to confirm the presence of heart disease, and most importantly to assess for risk factors associated with increased risk of CHF and ATE (e.g. left atrial size). Systemic diseases that may cause a murmur should also be excluded, i.e. check blood pressure, haematocrit and T4 (cats >6 years). Normal and HCM cats may have heart murmurs, but a loud murmur in a cat >6 years is more likely to be associated with HCM and further investigations are recommended. Early interventions in cardiomyopathic cats may reduce the risk of serious complications, thus early detection of occult cardiomyopathies is paramount.
-
-
-
The ethics of managing heart disease in pets
BSAVA Congress Proceedings 2021Authors: James Yeates, Tobi Wagner and Poppy BristowThere are always going to be ethical questions and concerns when introducing new treatment modalities, and rightly so. As veterinarians we must always have animal welfare at the forefront of our decision making. Heart disease is a very common disease in dogs and can have a huge impact on quality of life, a subject that until recent years has been largely unresearched in veterinary patients. When considering any treatment option we must always consider its likely effect on quality of life; expected detrimental effects weighed up against potential improvements, in addition to quantity of life expected to be gained. This is particularly challenging in veterinary patients when assessment of quality of life and decision making has to be made by proxy. Maintaining a good health related quality of life (HrQOL) is just as important as survival to most humans in chronic heart failure (Lewis et al. 2001) and is also more important than quantity of life in owners of cats and dogs with cardiac disease (Oyama et al 2008, Reynolds et al. 2010). It is imperative that with any intervention, be they medical or surgical that owners are fully informed of potential risks and consequences, and presented with the most up to date and accurate information candidly.
-
-
-
The team approach to the brachycephalic patient
BSAVA Congress Proceedings 2021Authors: Julia Riggs, Chris Shales and Lydia SmithThis is a recording of a session giving Congress delegates the opportunity to ask questions and discuss practical tips and techniques used by three experienced team members to manage their busy BOAS clinics. The session complement the pre-recorded seminars and other live sessions that form part of this stream and gives a very useful exchange of ideas and experiences in this challenging but rewarding area.
-
-
-
The value of a good hepatic biopsy
BSAVA Congress Proceedings 2021Author Penny WatsonThe results of blood and imaging tests are non-specific in liver disease, so a liver biopsy is usually indicated to give a diagnosis and allow most effective treatment. Certainly, steroids or copper chelators should never be used without justification from a liver biopsy. The clinician must decide the best way to perform this biopsy considering how stable the patient is, the financial resources of the owner and the relative reliability of the results obtained with different methods. There is also little point in taking a biopsy which is not representative of the underlying disease – if the sample is too small, or from the wrong place, or only from one of a number of organs affected with disease, it may lead to the wrong conclusions being drawn and the wrong, or incomplete, treatment protocols. Fine needle aspiration (FNA) cytology is not strictly a biopsy but a potential alternative to more invasive biopsies but beware becoming ‘liver FNA happy’ for fear of false diagnoses and wasting the client’s money. FNAs are only helpful in a small number of cases, predominantly for bile aspirates and to rule out feline hepatic lipidosis or lymphoma. Wedge biopsies taken at laparotomy or laparoscopy are the most reliable diagnostically.
-